News Roche to file Actemra in inflamed artery disease Drug successful in late stage trial for giant cell arteritis
News Novartis drug gets fast US review in AML Midostaurin also under review in rare disease systemic mastocytosis
News Neuralink gets okay for its first international trial Elon Musk's brain-computer interface (BCI) company Neuralink has been given the green light to test its device in tetraplegic patients in Canada
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends